Latham & Watkins Assists LG Chem in Securing CFIUS Clearance
LG Chem, Ltd., a leading global chemical company, has received clearance from the Committee on Foreign Investment in the United States (CFIUS) in connection with its acquisition of AVEO Oncology, a commercial stage, oncology-focused biopharmaceutical company. CFIUS concluded that there were no unresolved national security concerns with respect to the transaction.
Latham & Watkins LLP represented LG Chem in the CFIUS clearance process with a team led by Washington, D.C. counsel Ruchi Gill, with associates Julie Shin and Asia Cadet. The transaction was led by Orange County partner Daniel Rees, Orange County/New York partner Charles Ruck, and Hong Kong/Seoul partner Steve Kang.